The DOI matches its Crossref record; 252 of the 256 references it cites were found in a registry or an index.
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
Abstract
Clinical studies have revealed that breast cancers contain regions of intratumoral hypoxia (reduced oxygen availability), which activates hypoxia-inducible factors (HIFs). The relationship between intratumoral hypoxia, distant metastasis and cancer mortality has been well established. A major mechanism by which intratumoral hypoxia contributes to disease progression is through induction of the breast cancer stem cell (BCSC) phenotype. BCSCs are a small subpopulation of cells with the capability for self-renewal. BCSCs have been implicated in resistance to chemotherapy, disease recurrence, and metastasis. In this review, we will discuss our current understanding of the molecular mechanisms underlying HIF-dependent induction of the BCSC phenotype in response to hypoxia or chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypoxia-inducible factors (HIFs) play critical roles in cancer progression by activating the transcription of a large battery of genes encoding proteins that play key roles in angiogenesis, glucose metabolism, invasion/metastasis, stem cell specification, protumoral inflammatory responses, and tumor immune evasion (18, 23–27).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [27]
Citations
Cites
3 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
Self-citationRetractedSamanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460
Self-citationRetractedSamanta, D., Park, Y., Andrabi, S. A., Shelton, L. M., Gilkes, D. M., & Semenza, G. L. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0530 · Cited by 242
Self-citationRetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Bonnet, D. A., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 7,197
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Cited by
Sorted by citations
Hypoxia-inducible factors: cancer progression and clinical translation
Wicks, E. E., & Semenza, G. L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci159839 · Cited by 626
Self-citationHIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Bai, R., Li, Y., Jian, L., Yue-hui, Y., Zhao, L., & Wei, M. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01645-2 · Cited by 296
The role of hypoxia‐inducible factor 1 in tumor immune evasion
Li, Y., Wu, W., Wang, X., Fang, L., Adam, V., Nepovimová, E., Wu, Q., & Kuča, K. (2020) · Medicinal Research Reviews · doi:10.1002/med.21771 · Cited by 276
Targeting Breast Cancer Stem Cells
Zhang, L., Chen, W., Liu, S., & Chen, C. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.76187 · Cited by 196
Salman, S., Meyers, D. J., Wicks, E. E., Lee, S. N., Datan, E., Thomas, A. M., Anders, N. M., Hwang, Y., Lyu, Y., Yang, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156774 · Cited by 111
Self-citationVascular mimicry: Triggers, molecular interactions and in vivo models
Wechman, S. L., Emdad, L., Sarkar, D., Das, S. K., & Fisher, P. B. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.06.001 · Cited by 101
Crosstalk between autophagy and metabolic regulation of cancer stem cells
El-Hout, M., Cosialls, E., Mehrpour, M., & Hamaï, A. (2020) · Molecular Cancer · doi:10.1186/s12943-019-1126-8 · Cited by 100
Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis
Wang, R., Godet, I., Yang, Y., Salman, S., Lu, H., Lyu, Y., Zuo, Q., Wang, Y., Zhu, Y., Chen, C. O., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020490118 · Cited by 93
Self-citationLiu, X., Xie, P., Hao, N., Zhang, M., Liu, Y., Liu, P., Semenza, G. L., He, J., & Zhang, H. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109144118 · Cited by 93
Self-citationRole of hypoxia inducible factor-1 in cancer stem cells (Review)
Zhang, Q., Han, Z., Zhu, Y., Chen, J., & Li, W. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11655 · Cited by 90
Lu, H., Lyu, Y., Tran, T. M. L., Lan, J., Xie, Y., Yang, Y., Murugan, N. L., Wang, Y. J., & Semenza, G. L. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109757 · Cited by 54
Self-citationMenon, D. R., Hammerlindl, H., Torrano, J., Schaider, H., & Fujita, M. (2020) · Theranostics · doi:10.7150/thno.42523 · Cited by 57
Intratumoral hypoxia and mechanisms of immune evasion mediated by hypoxia-inducible factors
Semenza, G. L. (2021) · Physiology · doi:10.1152/physiol.00034.2020 · Cited by 64
Self-citationZheng, X., Dai, F., Feng, L., Zou, H., Li, F., & Xu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617597 · Cited by 46
RETRACTED: A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity
Sarnella, A., D’Avino, G., Hill, B. S., Alterio, V., Winum, J., Supuran, C. T., Simone, G. D., & Zannetti, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218405 · Cited by 44
RetractedWu, C., Zhuang, Y., Zhou, J., Liu, S., Wang, R., & Shu, P. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111500 · Cited by 43
Jo, M. J., Kim, B. G., Kim, W. Y., Lee, D.-H., Yun, H. K., Jeong, S., Park, S. H., Kim, B. R., Kim, J. L., Kim, D. Y., et al. (2021) · Cancers · doi:10.3390/cancers13225667 · Cited by 39
Liu, Y., Hua, F., Zhan, Y., Yang, Y., Xie, J., Cheng, Y., & Li, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00524-x · Cited by 36
Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis
Semenza, G. L. (2021) · Blood · doi:10.1182/blood.2021011043 · Cited by 39
Self-citationTrailblazing perspectives on targeting breast cancer stem cells
Li, J., Qi, D., Hsieh, T., Huang, J. H., WU, J. M., & Wu, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107800 · Cited by 33
Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1
Zhang, Y., Yue, C., Krichevsky, A. M., & Garkavtsev, I. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12915 · Cited by 34
Tian, T., Han, J., Huang, J. J., Li, S., & Pang, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.784777 · Cited by 31
Hypoxia-mediated changes in bone marrow microenvironment in breast cancer dormancy
Ferrer, A. I., Roser, C. T., El-Far, M. H., Savanur, V. H., Eljarrah, A., Gergues, M., Kra, J., Etchegaray, J., & Rameshwar, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.026 · Cited by 30
NARF is a hypoxia-induced coactivator for OCT4-mediated breast cancer stem cell specification
Yang, Y., Chen, C. O., Zuo, Q., Lu, H., Salman, S., Lyu, Y., Huang, T. Y.-T., Wicks, E. E., Jackson, W., Datan, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo5000 · Cited by 29
Self-citationHypoxia-Induced Non-Coding RNAs Controlling Cell Viability in Cancer
Barreca, M. M., Zichittella, C., Alessandro, R., & Conigliaro, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041857 · Cited by 26
Semenza, G. L. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad061 · Cited by 26
Self-citationCancer stem cells in breast and prostate: Fact or fiction?
Sampayo, R. G., & Bissell, M. J. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.010 · Cited by 23
Hajimolaali, M., Dorkoosh, F. A., & Antimisiaris, S. G. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2325963 · Cited by 25
Zhu, S., Li, Z., Zheng, D., Yu, Y., Xiang, J., Ma, X., Xu, D., Qiu, J., Yang, Z., Wang, Z., et al. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.12.002 · Cited by 20
Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy
Liu, L., Wu, D., Qian, Z., Ying, J., You, Y., Wang, Y., Zhang, F., Ning, X., Mei, J., Iqbal, J., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02682-8 · Cited by 20
Wu, K., Wu, M., Yang, H., Diao, R., & Zeng, H. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03093-w · Cited by 18
Hypoxia and lncRNAs in gastrointestinal cancers
Huang, L., Wang, W., Hu, Z., Guan, C., Li, W., & Jiang, X. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152687 · Cited by 18
Huang, X., Zhou, W., & Zhang, Y. (2020) · Environmental Toxicology · doi:10.1002/tox.23017 · Cited by 16
Zuo, Q., Yang, Y., Lyu, Y., Yang, C. G., Chen, C. O., Salman, S., Huang, T. Y.-T., Wicks, E. E., Jackson, W., Datan, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112164 · Cited by 15
Self-citationThe role of hypoxia-inducible factors in breast cancer stem cell specification
Fath, M. K., Garousi, S., Mottahedi, M., Ghasemzadeh, N., Salmani, K., Olfati, F., Saeed, M. B., Sotoudeh, S., & Barati, G. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154349 · Cited by 15
Zhang, J., Su, Q., Loudon, W. G., Lee, K. L., Luo, J., Dethlefs, B. A., & Li, S. C. (2019) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk4040071 · Cited by 14
Dai, H., Sheng, X., Wang, Y., Zhou, L., Lin, Y., Du, Y., Yang, F., Sha, R., Peng, J., Yao, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729965 · Cited by 13
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications
Chen, W., & Wang, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03408-x · Cited by 14
Liang, Y., Besch-Williford, C. L., Cook, M. T., Belenchia, A. M., Brekken, R. A., & Hyder, S. M. (2019) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s208706 · Cited by 12
Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs
Gutierrez-Cruz, J. A., Maldonado, V., & Meléndez-Zajgla, J. (2022) · Cells · doi:10.3390/cells11152352 · Cited by 12
Ruan, Y., Qiao, J., Wang, J., & Liu, Z. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01951-2 · Cited by 11
Zhao, J., Zhang, H., Liu, Y., Lu, G., Wang, Z., Mo, Q., Wang, G., Shen, Y., & Jiao, L.-Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37900 · Cited by 11
Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate
Xu, Y. J., Liu, J., Chen, W.-J., Ye, Q., Chen, W., Li, C., & Wu, H.-T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.561703 · Cited by 11
Zhang, H., Sun, Y., Liu, R., Hamdy, H., Shi, Z., Jiang, D., & Sun, J. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101315 · Cited by 10
Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents
Xiong, Z., Huang, W., Zhong, W., Fu, J., Feng, J., Wang, X., & Ling, F. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.900005 · Cited by 10
Hypothermia Alleviates Reductive Stress, a Root Cause of Ischemia Reperfusion Injury
Eskla, K., Vellama, H., Tarve, L., Eichelmann, H. Y., Jagomäe, T., Porosk, R., Oja, V., Rämma, H., Peet, N., Laisk, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710108 · Cited by 10
Lineage plasticity in prostate cancer: Looking beyond intrinsic alterations
Ferguson, A. M., & Rubin, M. A. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215901 · Cited by 10
Han, P., Zhang, B., Li, Y., Gao, R., Li, X., Ren, H., Shi, P., Zhao, A., Xue, J., Yang, A., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03129-7 · Cited by 9
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Semenza, G. L. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100075 · Cited by 10
Self-citationMalik, S., Sikander, M., Wahid, M., Dhasmana, A., Sarwat, M., Khan, S., Cobos, E., Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10177-8 · Cited by 9
Wang, J., Liu, R., Wang, Y., Mo, H., Niu, Y., Xu, Q., & Liu, Q. (2021) · Journal of Cancer · doi:10.7150/jca.58697 · Cited by 8
Zeidan, E. M., Hossain, M. A., El‐Daly, M., Abourehab, M. A. S., Khalifa, M. M. A., & Taye, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175219 · Cited by 8
Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment
Ji, G., Liu, J., Zhao, Z., Lan, J., Yang, Y., Wang, Z., Feng, H., Ji, K., Jiang, X., Xia, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202404853 · Cited by 8
The Significance of Epithelial Mesenchymal Transition (EMT) in Cancer Metastasis
Shaheen, S. Y. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2025.3941 · Cited by 5
PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19
Xue, T., Wang, X., Pan, X., Liu, M., & Xu, F. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111309 · Cited by 5
Zhang, Y., Guan, Y., Zheng, X., & Li, C. (2024) · BMC Cancer · doi:10.1186/s12885-024-11906-6 · Cited by 5
Tyrosol: Repercussion of the Lack of a Hydroxyl-Group in the Response of MCF-7 Cells to Hypoxia
Calahorra, J., Araujo‐Abad, S., Granadino‐Roldán, J. M., Naranjo, Á., Martínez‐Lara, E., & Siles, E. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2022.0096 · Cited by 4
Chao, T., Satriyo, P. B., Yeh, C., Chen, J.-H., Aryandono, T., & Haryana, S. M. (2020) · Journal of Cancer Research and Practice · doi:10.4103/jcrp.jcrp_13_20 · Cited by 4
Wang, R., & Yan, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1671115 · Cited by 2
HIF-1–mediated ISG20 expression promotes breast cancer stemness and immune evasion
Yang, Y., Zuo, Q., Ramu, V., Talwar, V., Lv, Y., Chen, C. O., Drehmer, D., Huang, T., Salman, S., Dordai, D. I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250777 · Cited by 2
Self-citationRoles of cancer stem cells in cancer immune surveillance
Truong, N. C., Huynh, N. T., Kmuong-Duy, P. H. A. M., & Pham, P. V. (2023) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.23.02944-9 · Cited by 1
Blood transfusion mediated tumor microenvironment remodeling in breast cancer
Yin, Q., Zhang, S., Ouchari, M., Wang, P., Zhao, A., Zeng, L., Wang, J., Yao, K., Tang, S., Ma, H., et al. (2025) · Acta Histochemica · doi:10.1016/j.acthis.2025.152289 · Cited by 1
He, Q., Yang, S., Xin, Q., Jiang, Y., Jiang, L., & Xu, N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47120974 · Cited by 1
Clinical strategies to inhibit tumor vascularization
Harris, A. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819494-2.00009-2 · Cited by 1
Prostata- und Mammakarzinom: Gemeinsamkeiten und Unterschiede
Kranz, J., Hoffmann, M., Krauss, K., Stickeler, E., & Saar, M. (2022) · Die Urologie · doi:10.1007/s00120-022-01913-5
Modulatory Effect of Vitamin C on Hypoxia Induced Breast Cancer Stem Cells
Kazemi, M., Montazersaheb, S., Noroozpour, M., Farajnia, S., & Charoudeh, H. N. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2023.073
Aliev, K. A., Asanova, E., Makalish, T. P., & Zyablitskaya, E. Y. (2024) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2024-31-5-26-40
Hydrostatic pressure activates HIF ‐1α via β‐catenin to promote stemness in breast cancer cells
Zhai, D., Xu, Y., Ma, J., Duangrat, R., Yan, C., Liang, J., Wei, H., Jiang, B., & Li, T. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70267
Guimarães‐Teixeira, C., Miranda‐Gonçalves, V., Henrique, R., & Jerónimo, C. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-12166-0_11
Metadata
- Authors
- Xiang, L., & Semenza, G. L.
- Affiliations
- Sichuan University (CN)
- Johns Hopkins University (US)
- Corresponding author
- Gregg L. Semenza
- Venue
- Advances in Cancer Research
- Publisher
- Elsevier
- Published
- 2019
- Volume
- 141
- Pages
- 175-212
- ISSN
- 0065-230X (ISSN-L)
- OpenAlex
- W2904539422
- Cited by
- 71
- References
- 256
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 10 · 2023: 8 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 5
- FWCI
- 9.82
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in cancer research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- hypoxia-inducible factor, breast cancer stem cells, intratumoral hypoxia, chemoresistance, self-renewal, metastasis, recurrence, HIF signaling
- MeSH terms
- Animals, Breast Neoplasms, Female, Humans, Neoplastic Stem Cells, Cell Hypoxia, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review